Changes related to "Breast cancer"

Jump to: navigation, search

This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide minor edits | Show bots | Hide anonymous users | Hide registered users | Hide my edits

Show new changes starting from 15:08, 25 June 2018
   
Page name:

24 June 2018

 m   09:59  Breast cancer‎ (diff | hist) . . (+398). . Jwarner (talk | contribs) (Capecitabine monotherapy {{#subobject:e058c1|Regimen=1}})

22 June 2018

 m   16:20  Breast cancer, HER2-positive‎ (diff | hist) . . (+281). . Jwarner (talk | contribs) (Lapatinib & Trastuzumab {{#subobject:da072f|Regimen=1}})
 m   13:26  Breast cancer, triple negative‎ (diff | hist) . . (+1,541). . Jwarner (talk | contribs) (Carboplatin & Paclitaxel {{#subobject:2926d1|Regimen=1}})

21 June 2018

 m   21:01  Complex multipart regimens‎‎ (2 changes | history) . . (+1,938). . [Jwarner‎ (2×)]
 m    21:01 (cur | prev) . . (+352). . Jwarner (talk | contribs)
 m    20:59 (cur | prev) . . (+1,586). . Jwarner (talk | contribs) (Diffuse large B-cell lymphoma)

20 June 2018

 m   15:13  Breast cancer, HER2-positive‎ (diff | hist) . . (-118). . Jwarner (talk | contribs)
     15:05  Breast cancer‎‎ (6 changes | history) . . (+3,855). . [Jwarner‎ (6×)]
 m    15:05 (cur | prev) . . (+17). . Jwarner (talk | contribs) (Variant #1, 20 mg/m2 weekly {{#subobject:96cac2|Variant=1}})
 m    11:01 (cur | prev) . . (-8). . Jwarner (talk | contribs) (Paclitaxel monotherapy, q3wk {{#subobject:3e5448|Regimen=1}})
 m    11:00 (cur | prev) . . (+1,748). . Jwarner (talk | contribs) (Gemcitabine & Bevacizumab {{#subobject:134dbe|Regimen=1}})
      10:56 (cur | prev) . . (+2,990). . Jwarner (talk | contribs) (Metastatic disease, maintenance after first-line therapy)
 m    10:52 (cur | prev) . . (+1,616). . Jwarner (talk | contribs) (Gemcitabine monotherapy {{#subobject:b240d6|Regimen=1}})
 m    10:49 (cur | prev) . . (-2,508). . Jwarner (talk | contribs) (GT (Taxol) {{#subobject:1285e|Regimen=1}})
 m   15:05  Breast cancer - historical‎‎ (2 changes | history) . . (+25). . [Jwarner‎ (2×)]
 m    15:05 (cur | prev) . . (+13). . Jwarner (talk | contribs) (Regimen {{#subobject:4da860|Variant=1}})
 m    15:04 (cur | prev) . . (+12). . Jwarner (talk | contribs) (VAC {{#subobject:90f8d0|Regimen=1}})

19 June 2018

 m   17:24  Breast cancer‎ (diff | hist) . . (-260). . Jwarner (talk | contribs)
 m   16:26  Breast cancer, triple negative‎‎ (2 changes | history) . . (+7,915). . [Jwarner‎ (2×)]
 m    16:26 (cur | prev) . . (+2,053). . Jwarner (talk | contribs) (Neoadjuvant chemotherapy)
 m    15:48 (cur | prev) . . (+5,862). . Jwarner (talk | contribs) (Adjuvant chemotherapy)
 m   15:48  Breast cancer, HER2-positive‎ (diff | hist) . . (+5,862). . Jwarner (talk | contribs) (Adjuvant chemotherapy)

18 June 2018

 m   23:15  Complex multipart regimens‎ (diff | hist) . . (0). . Jwarner (talk | contribs)
 m   13:48  Breast cancer, HER2-positive‎ (diff | hist) . . (+43). . Jwarner (talk | contribs)